Dark Forest Capital Management LP Innoviva, Inc. Transaction History

Dark Forest Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $193,677 - $223,207	13,302 New	13,302 $202,000
Q3 2023 Nov 13, 2023	BUY	$12.37 - $13.89 $345,085 - $387,489	27,897 Added 43.56%	91,947 $1.19 Million
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $729,529 - $878,766	64,050 New	64,050 $815,000
Q4 2022 Feb 13, 2023	SELL	$11.8 - $13.78 $14,136 - $16,508	-1,198 Reduced 99.17%	10 $0
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $14,024 - $18,385	1,208 New	1,208 $14,000
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $5,642 - $7,832	-394 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$15.39 - $20.25 $6,063 - $7,978	394 New	394 $8,000
Q4 2021 Feb 11, 2022	SELL	$15.91 - $18.72 $1,097 - $1,291	-69 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$13.06 - $17.24 $38,030 - $50,202	-2,912 Reduced 97.69%	69 $1,000
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $34,132 - $41,614	2,981 New	2,981 $40,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.